{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn), a 140 amino acid protein associated with presynaptic membranes in brain, is a major constituent of Lewy bodies in Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper establishes a direct link between α-syn and PD through its presence in Lewy bodies.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In the present study, we analysed the ability of cytosolic factors to regulate α-syn binding to synaptic membranes.",
          "judgment": "Yes",
          "reasoning": "Assessing α-syn's membrane binding in relation to cytosolic factors is relevant to understanding its localization and potential misfolding in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We show that co-incubation with brain cytosol significantly increases the membrane binding of normal and PD-linked mutant α-syn.",
          "judgment": "Yes",
          "reasoning": "The paper states that the experimental condition includes comparison to a 'normal' or 'wild-type' control, implying both are present.  The description of increased binding is consistent with comparing to an altered condition. Explicit replication details are not provided, but it can be inferred that the changes were observed and reported, implying it's been tested.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "In addition, the impaired membrane binding observed for A30P α-syn was significantly mitigated by the presence of protease-sensitive factors in brain cytosol.",
          "judgment": "Yes",
          "reasoning": "The text explicitly references another variant (A30P) as a negative control, using the observation that its binding is mitigated to understand the mechanism.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The paper establishes the pathogenic nature of SNCA A30P based on its impaired membrane binding and mitigation with cytosolic factors, which are compared with a 'normal' or 'wild-type' control.  Statistical details are not present."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn), a 140 amino acid protein associated with presynaptic membranes in brain, is a major constituent of Lewy bodies in Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper establishes a direct link between α-syn and PD through its presence in Lewy bodies.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In the present study, we analysed the ability of cytosolic factors to regulate α-syn binding to synaptic membranes.",
          "judgment": "Yes",
          "reasoning": "Assessing α-syn's membrane binding in relation to cytosolic factors is relevant to understanding its localization and potential misfolding in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We show that co-incubation with brain cytosol significantly increases the membrane binding of normal and PD-linked mutant α-syn.",
          "judgment": "Yes",
          "reasoning": "The paper states that the experimental condition includes comparison to a 'normal' or 'wild-type' control, implying both are present. Explicit replication details are not provided, but it can be inferred that the changes were observed and reported, implying it's been tested.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "In addition, the impaired membrane binding observed for A30P α-syn was significantly mitigated by the presence of protease-sensitive factors in brain cytosol.",
          "judgment": "Yes",
          "reasoning": "The text explicitly references another variant (A30P) as a negative control, using the observation that its binding is mitigated to understand the mechanism.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The paper establishes the pathogenic nature of SNCA A53T based on its impaired membrane binding and mitigation with cytosolic factors, which are compared with a 'normal' or 'wild-type' control. Statistical details are not present."
    }
  ]
}